{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:59:38Z","timestamp":1780631978011,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000269","name":"UK Research and Innovation Economic and Social Research Council","doi-asserted-by":"publisher","award":["ES\/P000592\/1"],"award-info":[{"award-number":["ES\/P000592\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S017968\/1"],"award-info":[{"award-number":["MR\/S017968\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015846","name":"Llywodraeth Cymru","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012360","name":"Heart of England NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/X015017\/1"],"award-info":[{"award-number":["MR\/X015017\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jclinepi.2025.111767","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T09:44:07Z","timestamp":1742982247000},"page":"111767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Emulating an existing trial of treatments for prostate cancer using real-world data: challenges and lessons learned"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6159-6520","authenticated-orcid":false,"given":"Caroline","family":"Chesang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda D.","family":"Sharples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9723-3032","authenticated-orcid":false,"given":"Christen M.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Nossiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6504-3253","authenticated-orcid":false,"given":"Ruth H.","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jclinepi.2025.111767_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111767_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/bju.14809","article-title":"Prostate cancer: diagnosis and management. (2019)","volume":"124","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.jclinepi.2025.111767_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1019-5","article-title":"The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study","volume":"16","author":"Gnanapragasam","year":"2018","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.jclinepi.2025.111767_bib4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111767_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cpt.1405","article-title":"Real-world evidence of treatment effects: the useful and the misleading","volume":"106","author":"Schneeweiss","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jclinepi.2025.111767_bib6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/aje\/kwz100","article-title":"Effect estimates in randomized trials and observational studies: comparing apples with apples","volume":"188","author":"Lodi","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111767_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/cpt.1793","article-title":"Emulation differences vs. Biases when calibrating real-world evidence findings against randomized controlled trials","volume":"107","author":"Franklin","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jclinepi.2025.111767_bib8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.120.051718","article-title":"Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative","volume":"143","author":"Franklin","year":"2021","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jclinepi.2025.111767_bib9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jama.2023.4221","article-title":"Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials","volume":"329","author":"Wang","year":"2023","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jclinepi.2025.111767_bib10","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/aje\/kwae137","article-title":"Cardiorenal effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET)","volume":"193","author":"Baptiste","year":"2024","journal-title":"Am J Epidemiol"},{"issue":"9809","key":"10.1016\/j.jclinepi.2025.111767_bib11","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(11)61095-7","article-title":"Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial","volume":"378","author":"Warde","year":"2011","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.jclinepi.2025.111767_bib12","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.2014.57.8724","article-title":"Impact of radiotherapy when added to androgen-deprivation therapy for locally advanced prostate cancer: long-term quality-of-life outcomes from the NCIC CTG PR3\/MRC PR07 randomized trial","volume":"33","author":"Brundage","year":"2015","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jclinepi.2025.111767_bib13","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1200\/JCO.2014.57.7510","article-title":"Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer","volume":"33","author":"Mason","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jclinepi.2025.111767_bib14","doi-asserted-by":"crossref","first-page":"k182","DOI":"10.1136\/bmj.k182","article-title":"How to estimate the effect of treatment duration on survival outcomes using observational data","volume":"360","author":"Hern\u00e1n","year":"2018","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.jclinepi.2025.111767_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","author":"Anderson","year":"1983","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111767_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1467-9469.2006.00529.x","article-title":"Dynamic prediction by landmarking in event history analysis","volume":"34","author":"Van Houwelingen","year":"2007","journal-title":"Scand J Stat"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111767_bib17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25-year landmark point","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jclinepi.2025.111767_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10985-015-9335-y","article-title":"Does Cox analysis of a randomized survival study yield a causal treatment effect?","volume":"21","author":"Aalen","year":"2015","journal-title":"Lifetime Data Anal"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111767_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"issue":"17","key":"10.1016\/j.jclinepi.2025.111767_bib20","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/eurheartj\/ehy770","article-title":"Limitations of hazard ratios in clinical trials","volume":"40","author":"Stensrud","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111767_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ije\/dyz076","article-title":"Data resource profile: national cancer registration dataset in England","volume":"49","author":"Henson","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111767_bib22","doi-asserted-by":"crossref","first-page":"f2350","DOI":"10.1136\/bmj.f2350","article-title":"Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study","volume":"346","author":"Herrett","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111767_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070699","article-title":"Cohort profile: radiotherapy dataset (RTDS) in England","volume":"13","author":"Sandhu","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111767_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111767_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2202\/1557-4679.1212","article-title":"When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data","volume":"6","author":"Cain","year":"2010","journal-title":"Int J Biostat"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111767_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40471-015-0045-5","article-title":"Methods to estimate the comparative effectiveness of clinical strategies that administer the same intervention at different times","volume":"2","author":"Huitfeldt","year":"2015","journal-title":"Curr Epidemiol Rep"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111767_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijrobp.2008.04.001","article-title":"Radiotherapy and survival in prostate cancer patients: a population-based study","volume":"73","author":"Zhou","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jclinepi.2025.111767_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.euros.2021.01.011","article-title":"Comparative survival outcomes of high-risk prostate cancer treated with radical prostatectomy or definitive radiotherapy regimens","volume":"26","author":"Aas","year":"2021","journal-title":"Eur Urol open Sci"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111767_bib29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/ije\/dyx015","article-title":"Data resource profile: hospital episode statistics admitted patient care (HES APC)","volume":"46","author":"Herbert","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111767_bib30","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2020.0117","article-title":"Concordance in the recording of stroke across UK primary and secondary care datasets: a population-based cohort study","volume":"5","author":"Morgan","year":"2021","journal-title":"BJGP Open"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111767_bib31","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ije\/dyaa057","article-title":"Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data","volume":"49","author":"Maringe","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111767_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0962280216628900","article-title":"Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator","volume":"27","author":"Willems","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"282","key":"10.1016\/j.jclinepi.2025.111767_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111767_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B (Methodological)"},{"issue":"12","key":"10.1016\/j.jclinepi.2025.111767_bib35","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/eurheartj\/ehi890","article-title":"Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jclinepi.2025.111767_bib36","author":"Greifer"},{"key":"10.1016\/j.jclinepi.2025.111767_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2020.10.019","article-title":"Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: a national population-based study","volume":"155","author":"Parry","year":"2021","journal-title":"Radiother Oncol"},{"issue":"9660","key":"10.1016\/j.jclinepi.2025.111767_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7\/SFUO-3): an open randomised phase III trial","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jclinepi.2025.111767_bib39","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111767_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term androgen deprivation for localized prostate cancer","volume":"365","author":"Jones","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:23:27Z","timestamp":1755649407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435625001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"alternative-id":["S0895435625001003"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111767","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emulating an existing trial of treatments for prostate cancer using real-world data: challenges and lessons learned","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111767"}}